BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32425600)

  • 21. High concordance rate of capillary electrophoresis workflow for microsatellite instability analysis and mismatch repair (MMR) immunostaining in colorectal carcinoma.
    Huang W; Ho CL; Lee CT; Chen WL; Yang SC; Chow NH; Chen YL
    PLoS One; 2023; 18(4):e0284227. PubMed ID: 37098015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordance between microsatellite instability testing and immunohistochemistry for mismatch repair proteins and efficient screening of mismatch repair deficient gastric cancer.
    Yamamoto G; Ito T; Suzuki O; Kamae N; Kakuta M; Takahashi A; Iuchi K; Arai T; Ishida H; Akagi K
    Oncol Lett; 2023 Nov; 26(5):494. PubMed ID: 37854865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status].
    Qin Y; Liang L; Zheng X; Zheng J; Ye J; Guo L; Zhao F; Shi X
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):704-8. PubMed ID: 26702526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients.
    Ren XY; Song Y; Wang J; Chen LY; Pang JY; Zhou LR; Shen SJ; Cao X; Wang YX; Shao MM; Liang ZY; Sun Q; Wu HW
    Front Oncol; 2021; 11():570623. PubMed ID: 33747906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
    Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
    Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing.
    Saeed OAM; Mann SA; Luchini C; Huang K; Zhang S; Sen JD; Piredda ML; Wang M; Baldrige LA; Sperling RM; Curless KL; Cheng L
    Hum Pathol; 2021 Sep; 115():10-18. PubMed ID: 34052294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
    Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical Expression of MMR Proteins with Clinicopathological Correlation in Colorectal Cancer in Egypt.
    Soliman NA; Morsia DF; Helmy NAH
    Open Access Maced J Med Sci; 2019 May; 7(10):1608-1617. PubMed ID: 31210809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Insight into Deficient Mismatch Repair Colorectal Cancer Screening in a Romanian Population-A Bi-Institutional Pilot Study.
    Lungulescu C; Croitoru VM; Volovat SR; Cazacu IM; Turcu-Stiolica A; Gheonea DI; Sur D; Lungulescu CV
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441055
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of microsatellite status detection methods in colorectal carcinoma.
    Chen ML; Chen JY; Hu J; Chen Q; Yu LX; Liu BR; Qian XP; Yang M
    Int J Clin Exp Pathol; 2018; 11(3):1431-1438. PubMed ID: 31938240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues.
    Mindiola-RomeroMD AE; GreenBS DC; Al-TurkmaniPhD MR; GodwinBS KN; MackayBS AC; TafeMD LJ; RenMD B; TsongalisPhD GJ
    Exp Mol Pathol; 2020 Oct; 116():104519. PubMed ID: 32822722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.
    Zhu L; Huang Y; Fang X; Liu C; Deng W; Zhong C; Xu J; Xu D; Yuan Y
    J Mol Diagn; 2018 Mar; 20(2):225-231. PubMed ID: 29277635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing.
    Ryan E; Sheahan K; Creavin B; Mohan HM; Winter DC
    Crit Rev Oncol Hematol; 2017 Aug; 116():38-57. PubMed ID: 28693799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers.
    Park Y; Nam SK; Seo SH; Park KU; Oh HJ; Park YS; Suh YS; Ahn SH; Park DJ; Kim HH; Lee HS
    J Gastric Cancer; 2023 Apr; 23(2):264-274. PubMed ID: 37129151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for microsatellite instability in colorectal carcinoma: Practical utility of immunohistochemistry and PCR with fragment analysis in a diagnostic histopathology setting.
    Cheah PL; Li J; Looi LM; Koh CC; Lau TP; Chang SW; Teoh KH; Mun KS; Nazarina AR
    Malays J Pathol; 2019 Aug; 41(2):91-100. PubMed ID: 31427545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns.
    Fountzilas E; Papadopoulos T; Papadopoulou E; Gouedard C; Kourea HP; Constantoulakis P; Magkou C; Sfakianaki M; Kotoula V; Bantouna D; Raptou G; Saetta AA; Christopoulou G; Hatzibougias D; Michalopoulou-Manoloutsiou E; Siatra E; Eleftheriadis E; Kavoura E; Kaklamanis L; Sourla A; Papaxoinis G; Pavlakis K; Hytiroglou P; Vourlakou C; Arapantoni-Dadioti P; Murray S; Nasioulas G; Timologos G; Fountzilas G; Saridaki Z
    Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
    McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
    Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer.
    Ukkola I; Nummela P; Pasanen A; Kero M; Lepistö A; Kytölä S; Bützow R; Ristimäki A
    Virchows Arch; 2021 Sep; 479(3):471-479. PubMed ID: 33755781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.